Russell Frank Company’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | $2.76M | Buy |
93,781
+20,552
| +28% | +$604K | ﹤0.01% | 1687 |
|
2015
Q4 | $2.45M | Sell |
73,229
-4,424
| -6% | -$148K | ﹤0.01% | 1711 |
|
2015
Q3 | $2.81M | Buy |
77,653
+8,088
| +12% | +$292K | 0.01% | 1646 |
|
2015
Q2 | $3.13M | Buy |
69,565
+57,979
| +500% | +$2.61M | 0.01% | 1717 |
|
2015
Q1 | $355K | Sell |
11,586
-39,513
| -77% | -$1.21M | ﹤0.01% | 2499 |
|
2014
Q4 | $2.61M | Buy |
51,099
+5,662
| +12% | +$289K | ﹤0.01% | 1633 |
|
2014
Q3 | $1.8M | Sell |
45,437
-1,596
| -3% | -$63.2K | ﹤0.01% | 1792 |
|
2014
Q2 | $1.77M | Buy |
47,033
+4,427
| +10% | +$167K | ﹤0.01% | 1821 |
|
2014
Q1 | $1.59M | Buy |
42,606
+2,460
| +6% | +$92K | ﹤0.01% | 1876 |
|
2013
Q4 | $1.47M | Buy |
40,146
+40,126
| +200,630% | +$1.47M | ﹤0.01% | 1891 |
|
2013
Q3 | $0 | Buy |
+20
| New | – | ﹤0.01% | 3458 |
|